Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial
- Author
- DETKE, Michael J1 2 3 4 ; YILI LU1 ; GOLDSTEIN, David J1 5 ; HAYES, John R1 2 ; DEMITRACK, Mark A1 2
[1] Lilly Research Laboratories, Eli Lilly and Company, Indianapolis,Ind., United States
[2] Department of Psychiatry, Indiana University Medical School, Indianapolis, United States
[3] Departments of Psychiatry, McLean Hospital, Belmont, United States
[4] Department of PsychiatryHarvard Medical School, Boston, Mass., United States
[5] Department of Pharmacology and Toxicology, Indiana University Medical School, Indianapolis, United States - Source
The Journal of clinical psychiatry. 2002, Vol 63, Num 4, pp 308-315 ; ref : 315 ref
- ISSN
- 0160-6689
- Scientific domain
- Psychology, psychopathology, psychiatry
- Publisher
- Physicians Postgraduate Press, Memphis, TN
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antidépresseur Chimiothérapie Douleur Duloxétine Efficacité traitement Etat dépressif Etude longitudinale Etude multicentrique Homme Inhibiteur recapture Noradrénaline Plainte somatique Psychotrope Relation dose réponse Symptomatologie Sérotonine Toxicité Traitement Trouble humeur
- Keyword (en)
- Antidepressant agent Chemotherapy Pain Duloxetine Treatment efficiency Depression Follow up study Multicenter study Human Reuptake inhibitor Norepinephrine Somatic complaint Psychotropic Dose activity relation Symptomatology Serotonin Toxicity Treatment Mood disorder
- Keyword (es)
- Antidepresor Quimioterapia Dolor Duloxetina Eficacia tratamiento Estado depresivo Estudio longitudinal Estudio multicéntrico Hombre Inhibidor recaptura Noradrenalina Queja somática Psicotropo Relación dosis respuesta Sintomatología Serotonina Toxicidad Tratamiento Trastorno humor
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 13636474
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.4088/JCP.v63n0407 
https://dx.doi.org/10.4088/JCP.v63n0407
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.4088\/JCP.v63n0407\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"308\";s:8:\"\u0000*\u0000epage\";s:3:\"315\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DETKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"YILI LU\";i:1;s:18:\"GOLDSTEIN, David J\";i:2;s:13:\"HAYES, John R\";i:3;s:17:\"DEMITRACK, Mark A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.4088\/JCP.v63n0407\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"308\";s:8:\"\u0000*\u0000epage\";s:3:\"315\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DETKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"YILI LU\";i:1;s:18:\"GOLDSTEIN, David J\";i:2;s:13:\"HAYES, John R\";i:3;s:17:\"DEMITRACK, Mark A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.4088\/JCP.v63n0407\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.4088\/JCP.v63n0407\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"308\";s:8:\"\u0000*\u0000epage\";s:3:\"315\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DETKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"YILI LU\";i:1;s:18:\"GOLDSTEIN, David J\";i:2;s:13:\"HAYES, John R\";i:3;s:17:\"DEMITRACK, Mark A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.4088\/JCP.v63n0407\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"308\";s:8:\"\u0000*\u0000epage\";s:3:\"315\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DETKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"YILI LU\";i:1;s:18:\"GOLDSTEIN, David J\";i:2;s:13:\"HAYES, John R\";i:3;s:17:\"DEMITRACK, Mark A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.4088\/JCP.v63n0407\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of clinical psychiatry\";s:9:\"\u0000*\u0000stitle\";s:19:\"J. clin. psychiatry\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"308\";s:8:\"\u0000*\u0000epage\";s:3:\"315\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0160-6689\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"DETKE\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:7:\"YILI LU\";i:1;s:18:\"GOLDSTEIN, David J\";i:2;s:13:\"HAYES, John R\";i:3;s:17:\"DEMITRACK, Mark A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:111:\"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial\";s:8:\"\u0000*\u0000place\";s:11:\"Memphis, TN\";s:6:\"\u0000*\u0000pub\";s:29:\"Physicians Postgraduate Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
